CTGen develops proprietary products with commercial applications in the genomic fields. The company's expertise in nucleic acid chemistries has led to the development of patented process and methods that make the synthesis and purification of DNA easier in a cost and time efficient process.

The frit technologies for DNA synthesis "EZfrit" and the Universal support UL1 have been successfully developed and will provide cost-effective approaches to your high throughput synthesis of nucleic acids. CTGen expects to enter an initial commercialization phase of UL1 EZfrits and TAMRA EZfrits in spring 2003.

The Company's purification technologies (MOP system) enhance the performance of your syntheses by delivering highly pure DNA or RNA. To further industrialize this process, the Company developed a high throughput platform and has purified thousands of oligonucleotides. CTGen also custom- purifies specialty oligonucleotides employing its proprietary chemistry.